Investors

We maintain a transparent, comprehensive dialogue with the financial community about our strategy, outlook, financial data, economic environment, and social impact.

/assets/dotcom/content-app/events/banner-investors-events_20230703194346.jpg

Fourth Quarter and Full Year 2024 Results

Fourth quarter and full year 2024 results were reviewed by management during a live audio webcast with the financial community on January 30, 2025. The presentation was followed by a Q&A session.  

Thursday January 30, 2025
15:00 - 16:30 CET (9:00am – 10:30am EST)

Upcoming Events

24Apr

2025

First Quarter 2025

First quarter 2025 results will be reviewed by management during a live audio webcast with the financial community on April 24, 2025. The presentation will be followed by a Q&A session.

13:00 - 14:30 CET (7:00am – 8:30am EDT)

Quarterly Results


30Apr

2025

Annual General Meeting 2025

The Sanofi General Meeting will be held on April 30, 2025 at the Palais des Congrès in Paris, Porte Maillot. It will be live video webcasted.

14:30 - 16:30

Annual General Meeting (AGM)


31Jul

2025

Second Quarter 2025

Second quarter 2025 results will be reviewed by management during a live audio webcast with the financial community on July 31, 2025. The presentation will be followed by a Q&A session.

15:00 - 16:30 CET (9:00am – 10:30am EDT)

Quarterly Results


Press Releases


February 22, 2025
Press Release: ECCO 2025: new duvakitug data reinforce best-in-class potential in ulcerative colitis and Crohn’s disease

February 19, 2025
Press Release: Sanofi and CD&R sign Opella share purchase agreement

February 18, 2025
Press Release: Dupixent sBLA accepted for FDA priority review for the targeted treatment of bullous pemphigoid

Dr. Lingaraju checks the health of Manikantan as his sister Geetha watches closely inside the Billigiri Ranganathaswamy Temple Tiger Reserve in Chamrajanagara district, Karnataka state, India

Environment, Social, Governance

As a global pharmaceutical company, we stretch everyday to deliver safe and sustainable innovation and play our part in addressing some of the world’s most pressing challenges.

Karine Roblot, wearing a light green protective suit, operating steel equipment with lots of valves, gauges and tubing
Karine Roblot, Vaccine Formulation Technician, Val de Reuil, France

2024 20-F

Presenting our 2024 FORM 20-F.

Subscribe to investor email alerts

Sign up to receive email alerts for various types of investor content

Contact Our Investor Relations Team

To join the Sanofi front desk,

Please contact the Global Headquarters in France :
+33 (0)1 53 77 40 00

To contact the Investor Relations team:

46 avenue de la Grande Armée
75017 Paris FRANCE
investor.relations (at) sanofi.com